CUDC-101
Cat.No:IC1830 Solarbio
CAS:1012054-59-9
Molecular Formula:C24H26N4O4
Molecular Weight:434.49
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Angiogenesis >
CUDC-101CAS:1012054-59-9
Molecular Formula:C24H26N4O4
Molecular Weight:434.49
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
CAS | 1012054-59-9 |
Name | CUDC-101 |
Molecular Formula | C24H26N4O4 |
Molecular Weight | 434.49 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD15528940 |
SMILES | C#CC1=CC=CC(NC2=NC=NC3=CC(OC)=C(C=C23)OCCCCCCC(NO)=O)=C1 |
InChIKey | PLIVFNIUGLLCEK-UHFFFAOYSA-N |
InChI | InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27) |
PubChem CID | 24756910 |
Target Point | EGFR;HDAC;HER2 |
Passage | Angiogenesis; Protein Tyrosine Kinase/RTK |
Background | CUDC-101 is a potent HDAC, EGFR and HER2 inhibitor. |
Biological Activity | CUDC-101 是一种高效的 HDAC、EGFR 和 HER2 抑制剂,对应的 IC50 值分别为 4.4、2.4 和 15.7 nM[1-4]。 |
Data Literature Source | [1]. Xiong Cai et al Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC,EGFR,and HER2 Inhibitor for the Treatment of Cancer J. Med. Chem.,2010,53 (5),pp 2000–2009 [2]. Sun H,et al. CUDC-101,a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy. Horm Cancer. 2016 Jun;7(3):196-210. [3]. Zhang L,et al. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. Oncotarget. 2015 Apr 20;6(11):9073-85. [4]. Lai CJ,et al. CUDC-101,a multitargeted inhibitor of histone deacetylase,epidermal growth factor receptor,and human epidermal growth factor receptor 2,exerts potent anticancer activity.Cancer Res. 2010 May 1;70(9):3647-56. Epub 2010 Apr 13 |
Unit | Piece |
Specification | 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.